Search Results - "Lodise, Thomas P"

Refine Results
  1. 1
  2. 2

    Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults: A Systematic Review and Meta-Analysis by Luther, Megan K., Timbrook, Tristan T., Caffrey, Aisling R., Dosa, David, Lodise, Thomas P., LaPlante, Kerry L.

    Published in Critical care medicine (01-01-2018)
    “…OBJECTIVES:The objective of this systematic review and meta-analysis was to assess acute kidney injury with combination therapy of vancomycin plus…”
    Get full text
    Journal Article
  3. 3

    Innovative approaches to optimizing the delivery of vancomycin in individual patients by Pai, Manjunath P., Neely, Michael, Rodvold, Keith A., Lodise, Thomas P.

    Published in Advanced drug delivery reviews (20-11-2014)
    “…The delivery of personalized antimicrobial therapy is a critical component in the treatment of patients with invasive infections. Vancomycin, the drug of…”
    Get full text
    Journal Article
  4. 4

    Are Vancomycin Trough Concentrations Adequate for Optimal Dosing? by NEELY, Michael N, YOUN, Gilmer, JONES, Brenda, JELLIFFE, Roger W, DRUSANO, George L, RODVOLD, Keith A, LODISE, Thomas P

    Published in Antimicrobial Agents and Chemotherapy (01-01-2014)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  5. 5

    Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized Patients by Lodise, Thomas P., Patel, Nimish, Lomaestro, Ben M., Rodvold, Keith A., Drusano, George L.

    Published in Clinical infectious diseases (15-08-2009)
    “…Background. Data suggest that higher doses of vancomycin can increase the risk of nephrotoxicity. No study has been undertaken to determine the pharmacodynamic…”
    Get full text
    Journal Article
  6. 6

    Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk? by Bidell, Monique R., Lodise, Thomas P.

    Published in Pharmacotherapy (01-06-2016)
    “…Fluoroquinolone antibiotics recently have gained increased national attention due to safety concerns. A well‐described and serious adverse event associated…”
    Get full text
    Journal Article
  7. 7

    Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity by LODISE, Thomas P, LOMAESTRO, Ben, GRAVES, Jeffrey, DRUSANO, G. L

    Published in Antimicrobial Agents and Chemotherapy (01-04-2008)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  8. 8

    Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections by Shorr, Andrew F, Lodise, Thomas P, Corey, G Ralph, De Anda, Carisa, Fang, Edward, Das, Anita F, Prokocimer, Philippe

    Published in Antimicrobial agents and chemotherapy (01-02-2015)
    “…Tedizolid, a novel oxazolidinone with activity against a wide range of Gram-positive pathogens, was evaluated in two noninferiority phase 3 acute bacterial…”
    Get full text
    Journal Article
  9. 9

    Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy by Lodise, Thomas P., Lomaestro, Ben, Drusano, George L.

    Published in Clinical infectious diseases (01-02-2007)
    “…Background.Piperacillin-tazobactam is frequently used to treat Pseudomonas aeruginosa infections in critically ill patients. In an effort to improve clinical…”
    Get full text
    Journal Article
  10. 10

    Hospital Readmissions and Mortality Among Intubated and Mechanically Ventilated Adult Subjects With Pneumonia Due to Gram-Negative Bacteria by Lodise, Jr, Thomas P, Law, Amy, Spilsbury-Cantalupo, Monica, Liao, Laura, McCart, Melissa, Eaddy, Michael

    Published in Respiratory care (01-05-2021)
    “…Ventilator-associated pneumonia (VAP) is one of the most common hospital-acquired infections in ICUs and is associated with significant morbidity and…”
    Get full text
    Journal Article
  11. 11

    A systematic review of the association between delayed appropriate therapy and mortality among patients hospitalized with infections due to Klebsiella pneumoniae or Escherichia coli: how long is too long? by Lodise, Thomas P, Zhao, Qi, Fahrbach, Kyle, Gillard, Patrick J, Martin, Amber

    Published in BMC infectious diseases (05-12-2018)
    “…Temporal relationships between the time to appropriate antibiotic therapy and outcomes are not well described. A systematic literature review and meta-analysis…”
    Get full text
    Journal Article
  12. 12

    Predictors of 30-Day Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: Impact of Delayed Appropriate Antibiotic Selection by LODISE, Thomas P, PATEL, Nimish, KWA, Andrea, GRAVES, Jeffrey, FURUNO, Jon P, GRAFFUNDER, Eileen, LOMAESTRO, Ben, MCGREGOR, Jessina C

    Published in Antimicrobial Agents and Chemotherapy (01-10-2007)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence by Viale, Pierluigi, Sandrock, Christian E., Ramirez, Paula, Rossolini, Gian Maria, Lodise, Thomas P.

    Published in Annals of intensive care (15-06-2023)
    “…Appropriate antibiotic treatment for critically ill patients with serious Gram-negative infections in the intensive care unit is crucial to minimize morbidity…”
    Get full text
    Journal Article
  17. 17

    Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections by Lodise, Thomas P, Bonine, Nicole Gidaya, Ye, Jiatao Michael, Folse, Henry J, Gillard, Patrick

    Published in BMC infectious diseases (14-08-2019)
    “…We developed a clinical bedside tool to simultaneously estimate the probabilities of third-generation cephalosporin-resistant Enterobacteriaceae (3GC-R),…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Economic Impact of Oritavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in the Emergency Department or Observation Setting: Cost Savings Associated with Avoidable Hospitalizations by Lodise, Thomas P., PharmD, PhD, Fan, Weihong, MS, Sulham, Katherine A., MPH

    Published in Clinical therapeutics (01-01-2016)
    “…Abstract Purpose Data indicate that acute bacterial skin and skin structure infection (ABSSSI) patients without major comorbidities can be managed effectively…”
    Get full text
    Journal Article
  20. 20

    Management of meningitis due to antibiotic-resistant Acinetobacter species by Kim, Baek-Nam, MD, Peleg, Anton Y, FRACP, Lodise, Thomas P, PharmD, Lipman, Jeffrey, MD, Li, Jian, PhD, Nation, Roger, PhD, Paterson, David L, FRACP

    Published in The Lancet infectious diseases (01-04-2009)
    “…Summary Acinetobacter meningitis is becoming an increasingly common clinical entity, especially in the postneurosurgical setting, with mortality from this…”
    Get full text
    Journal Article